Skip to main content

Advertisement

Log in

Iatrogenic Cushing’s syndrome and secondary adrenal insufficiency after a single intra-articular administration of triamcinolone acetonide in HIV-infected patients treated with ritonavir

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The development of an iatrogenic Cushing’s syndrome (ICS) followed by secondary adrenal failure remains an exceptional event after a single dose administration of a synthetic glucocorticoid. Medical attention has been drawn recently on the possible impact of ritonavir-based antiretroviral regimens on the systemic deleterious effects of a chronic administration of corticosteroids in HIV-infected patients. Three HIV-infected patients treated by a ritonavir-boosted protease inhibitor (PI) regimen received a single intra-articular injection of 40 mg triamcinolone acetonide in our university hospital. The three patients rapidly developed signs and symptoms of ICS followed by secondary adrenal insufficiency. Special attention must be paid when a single administration of corticosteroids has to be given in HIV-positive patients under ritonavir-boosted antiretroviral treatment, as these patients are at risk of developing early cushingoid features and a prolonged suppression of their hypothalamic–pituitary–adrenal axis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Girre C, Vincens M, Fournier PE (1987) Iatrogenic Cushing’s syndrome caused by an acute overdose of triamcinolone. Therapie 42:317–318

    PubMed  CAS  Google Scholar 

  2. Iglesias P, Gonzalez J, Diez JJ (2005) Acute and persistent iatrogenic Cushing’s syndrome after a single dose of triamcinolone acetonide. J Endocrinol Invest 28:1019–1023

    PubMed  CAS  Google Scholar 

  3. Jansen TL, Van Roon EN (2002) Four cases of a secondary cushingoid state following local triamcinolone acetonide (Kenacort®) injection. Neth J Med 60:151–153

    PubMed  Google Scholar 

  4. Armstrong RD, English J, Gibson T, Chakraborty J, Marks V (1981) Serum methylprednisolone levels following intra-articular injection of methylprednisolone acetate. Ann Rheum Dis 40:571–574

    Article  PubMed  CAS  Google Scholar 

  5. Köhler BE, Urowitz B, Killinger DW (1974) The systemic effects of intra-articular corticosteroids. J Rheumatol 1:117–124

    Google Scholar 

  6. Möllmann HW, Barth J, Haack D et al (1986) Comparative studies on the pharmacokinetics and duration of effect of intra-articular application of glucocorticoid crystal suspensions. Aktuelle Rheumatol 11:55–60

    Article  Google Scholar 

  7. Lazarevic MB, Skosey JL, Djordjevic-Denic G, Zgradic I (1995) Reduction of cortisol levels after single intra-articular and intramuscular steroid injection. The Am J Med 99:370–373

    Article  CAS  Google Scholar 

  8. Wicki J, Droz M, Cirafici L, Vallotton MB (2000) Acute adrenal crisis in a patient with intraarticular steroid therapy. J Rheumatol 27(2):510–511

    PubMed  CAS  Google Scholar 

  9. Gillett MJ, Cameron PU, Nguyen HV, Hurley DM, Mallal SA (2005) Iatrogenic Cushing syndrome in an HIV-infected patient treated with ritonavir and inhaled fluticasone. AIDS 19:740–741

    Article  PubMed  Google Scholar 

  10. Samaras K, Pett S, Gowers A, McMurchie M, Cooper DA (2005) Iatrogenic Cushing syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors six cases. J Clin Endocrinol Metab 90:4394–4398

    Article  PubMed  CAS  Google Scholar 

  11. Zeldin RK, Petruschke RA (2004) Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients. Antimicrob Chemother 53:4–9

    Article  CAS  Google Scholar 

  12. Penzak SR, Formentini E, Alfaro RM, Long M, Kovacs P (2005) Prednisolone pharmacokinetics in presence and absence of ritonavir after oral prednisone administration to healthy volunteers. J Acquir Immune Defic Syndr 40:573–580

    Article  PubMed  CAS  Google Scholar 

  13. Gupta SK, Dube MP (2002) Exogenous Cushing syndrome mimicking human immunodeficiency virus lipodystrophy. Clin Infect Dis 35:E69–E71

    Article  PubMed  Google Scholar 

Download references

Disclosures

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. C. Yombi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yombi, J.C., Maiter, D., Belkhir, L. et al. Iatrogenic Cushing’s syndrome and secondary adrenal insufficiency after a single intra-articular administration of triamcinolone acetonide in HIV-infected patients treated with ritonavir. Clin Rheumatol 27 (Suppl 2), 79–82 (2008). https://doi.org/10.1007/s10067-008-1022-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-008-1022-x

Keywords

Navigation